HEADER IMMUNE SYSTEM 28-JAN-16 5FUO TITLE EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A TITLE 2 HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION TITLE 3 INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERUM ALBUMIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FAB645-HSA; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: FAB HEAVY CHAIN; COMPND 8 CHAIN: H; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: FAB LIGHT CHAIN; COMPND 12 CHAIN: L; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: TESTIS; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 ORGAN: TESTIS; SOURCE 15 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 16 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 18 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 ORGAN: TESTIS; SOURCE 24 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 25 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 26 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 27 EXPRESSION_SYSTEM_CELL_LINE: CHO KEYWDS IMMUNE SYSTEM, ANTI-ALBUMIN, FAB FRAGMENT, SERUM HALF-LIFE, FCRN, KEYWDS 2 HUMAN SERUM ALBUMIN EXPDTA X-RAY DIFFRACTION AUTHOR R.ADAMS,T.CESKA REVDAT 4 23-OCT-24 5FUO 1 REMARK REVDAT 3 10-JAN-24 5FUO 1 REMARK REVDAT 2 09-NOV-16 5FUO 1 JRNL REVDAT 1 29-JUN-16 5FUO 0 JRNL AUTH R.ADAMS,L.GRIFFIN,J.E.COMPSON,M.JAIRAJ,T.BAKER,T.CESKA, JRNL AUTH 2 S.WEST,O.ZACCHEO,E.DAVE,A.D.G.LAWSON,D.P.HUMPHREYS,S.HEYWOOD JRNL TITL EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION JRNL TITL 2 OF A HUMANIZED ANTI-HUMAN SERUM ALBUMIN FV DOMAIN: AN JRNL TITL 3 INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND JRNL TITL 4 SERUM HALF-LIFE. JRNL REF MABS V. 8 1336 2016 JRNL REFN ISSN 1942-0862 JRNL PMID 27315033 JRNL DOI 10.1080/19420862.2016.1185581 REMARK 2 REMARK 2 RESOLUTION. 3.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.3 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 24409 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.600 REMARK 3 FREE R VALUE TEST SET COUNT : 2405 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.73 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2209 REMARK 3 BIN R VALUE (WORKING SET) : 0.3256 REMARK 3 BIN FREE R VALUE : 0.3713 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 2405 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.007 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7869 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 13.94600 REMARK 3 B22 (A**2) : 13.94600 REMARK 3 B33 (A**2) : -27.89200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.442 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.200 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.160 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.470 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.520 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 64.83 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : CNS_TOPPAR WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : CNS_TOPPAR ION.PARAM REMARK 3 PARAMETER FILE 5 : CNS_TOPPAR CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : A REMARK 3 TOPOLOGY FILE 2 : A REMARK 3 TOPOLOGY FILE 3 : A REMARK 3 TOPOLOGY FILE 4 : A REMARK 3 TOPOLOGY FILE 5 : A REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: CHAIN A RESIDUES 1-4, 583-585 AND CHAIN REMARK 3 H RESIDUES 136-142, 224-233 ARE TOO DISORDERED TO MODEL REMARK 4 REMARK 4 5FUO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1290062219. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9713 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46115 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.580 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.600 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.01000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.5700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.04000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.640 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4G03 AND FAB WWPDB SUBMISSION CODE 62161 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 73.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M CITRIC ACID PH 4.4, 0.1 M DI REMARK 280 -SODIUM HYDROGEN PHOSPHATE, 38% V/V ETHANOL, 5% V/V POLYETHYLENE REMARK 280 GLYCOL 1000, PH 1 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 26.21667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 52.43333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 52.43333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 26.21667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 55800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ALA A 2 REMARK 465 HIS A 3 REMARK 465 LYS A 4 REMARK 465 GLY A 584 REMARK 465 LEU A 585 REMARK 465 SER H 136 REMARK 465 LYS H 137 REMARK 465 SER H 138 REMARK 465 THR H 139 REMARK 465 SER H 140 REMARK 465 GLY H 141 REMARK 465 GLY H 142 REMARK 465 ASP H 225 REMARK 465 LYS H 226 REMARK 465 THR H 227 REMARK 465 HIS H 228 REMARK 465 HIS H 229 REMARK 465 HIS H 230 REMARK 465 HIS H 231 REMARK 465 HIS H 232 REMARK 465 HIS H 233 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 583 CA C O CB CG CD1 CD2 REMARK 470 CYS H 224 CA C O CB SG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 369 CA - CB - SG ANGL. DEV. = 7.6 DEGREES REMARK 500 PRO A 416 C - N - CA ANGL. DEV. = 9.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 31 76.55 -114.23 REMARK 500 GLN A 32 1.97 -68.13 REMARK 500 GLU A 48 -70.02 -63.57 REMARK 500 ASP A 56 83.82 -176.93 REMARK 500 ASN A 61 4.83 80.01 REMARK 500 SER A 65 155.07 -49.06 REMARK 500 VAL A 77 45.83 -142.00 REMARK 500 THR A 79 40.46 -84.80 REMARK 500 THR A 83 -17.91 -148.69 REMARK 500 TYR A 84 -69.67 -120.94 REMARK 500 HIS A 105 35.47 -95.81 REMARK 500 ASN A 111 46.27 -77.80 REMARK 500 PRO A 118 -170.64 -57.71 REMARK 500 ASP A 129 -81.04 -60.41 REMARK 500 TYR A 150 99.30 -65.26 REMARK 500 PHE A 223 60.17 -118.76 REMARK 500 ASP A 269 5.40 -58.91 REMARK 500 ILE A 271 -62.48 -129.91 REMARK 500 GLU A 280 -63.15 -108.44 REMARK 500 LYS A 281 157.53 -30.43 REMARK 500 ALA A 300 -116.04 -42.46 REMARK 500 ASP A 301 83.00 -56.36 REMARK 500 ALA A 306 -19.84 -49.23 REMARK 500 VAL A 310 -46.78 -135.26 REMARK 500 SER A 312 151.91 -44.86 REMARK 500 ILE A 388 -73.09 -66.33 REMARK 500 LYS A 389 -38.97 -38.27 REMARK 500 GLU A 442 9.40 -59.08 REMARK 500 ALA A 449 -70.81 -57.07 REMARK 500 LYS A 466 -71.06 -50.38 REMARK 500 GLU A 479 -153.13 -63.33 REMARK 500 ARG A 485 -70.33 -58.59 REMARK 500 LEU A 491 147.27 -20.40 REMARK 500 THR A 496 -71.73 -60.76 REMARK 500 TYR A 497 139.63 -16.88 REMARK 500 LYS A 500 38.50 -76.33 REMARK 500 GLU A 501 -133.53 69.99 REMARK 500 PHE A 502 86.65 -178.18 REMARK 500 ALA A 504 -7.73 -57.25 REMARK 500 CYS A 514 0.11 -69.91 REMARK 500 LYS A 536 61.27 -158.57 REMARK 500 PRO A 537 -129.81 -72.65 REMARK 500 LYS A 538 -84.27 24.28 REMARK 500 THR A 540 116.90 170.33 REMARK 500 LYS A 541 -125.56 -113.27 REMARK 500 GLU A 565 -7.42 79.37 REMARK 500 GLU A 571 30.73 -77.12 REMARK 500 GLN A 580 33.03 -88.11 REMARK 500 SER H 7 162.40 169.43 REMARK 500 LEU H 29 -20.74 73.74 REMARK 500 REMARK 500 THIS ENTRY HAS 87 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FUC RELATED DB: PDB REMARK 900 BIOPHYSICAL AND CELLULAR CHARACTERISATION OF A JUNCTIONAL EPITOPE REMARK 900 ANTIBODY THAT LOCKS IL-6 AND GP80 TOGETHER IN A STABLE COMPLEX: REMARK 900 IMPLICATIONS FOR NEW THERAPEUTIC STRATEGIES REMARK 900 RELATED ID: 5FUZ RELATED DB: PDB REMARK 900 EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A REMARK 900 HUMANISED ANTI-HUMAN SERUM ALBUMIN ( HSA) FV DOMAIN: AN REMARK 900 INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF- REMARK 900 LIFE REMARK 999 REMARK 999 SEQUENCE REMARK 999 IN-HOUSE DISCOVERED FAB DBREF 5FUO A 1 585 UNP P02768 ALBU_HUMAN 25 609 DBREF 5FUO H 1 233 PDB 5FUO 5FUO 1 233 DBREF 5FUO L 1 217 PDB 5FUO 5FUO 1 217 SEQRES 1 A 585 ASP ALA HIS LYS SER GLU VAL ALA HIS ARG PHE LYS ASP SEQRES 2 A 585 LEU GLY GLU GLU ASN PHE LYS ALA LEU VAL LEU ILE ALA SEQRES 3 A 585 PHE ALA GLN TYR LEU GLN GLN CYS PRO PHE GLU ASP HIS SEQRES 4 A 585 VAL LYS LEU VAL ASN GLU VAL THR GLU PHE ALA LYS THR SEQRES 5 A 585 CYS VAL ALA ASP GLU SER ALA GLU ASN CYS ASP LYS SER SEQRES 6 A 585 LEU HIS THR LEU PHE GLY ASP LYS LEU CYS THR VAL ALA SEQRES 7 A 585 THR LEU ARG GLU THR TYR GLY GLU MET ALA ASP CYS CYS SEQRES 8 A 585 ALA LYS GLN GLU PRO GLU ARG ASN GLU CYS PHE LEU GLN SEQRES 9 A 585 HIS LYS ASP ASP ASN PRO ASN LEU PRO ARG LEU VAL ARG SEQRES 10 A 585 PRO GLU VAL ASP VAL MET CYS THR ALA PHE HIS ASP ASN SEQRES 11 A 585 GLU GLU THR PHE LEU LYS LYS TYR LEU TYR GLU ILE ALA SEQRES 12 A 585 ARG ARG HIS PRO TYR PHE TYR ALA PRO GLU LEU LEU PHE SEQRES 13 A 585 PHE ALA LYS ARG TYR LYS ALA ALA PHE THR GLU CYS CYS SEQRES 14 A 585 GLN ALA ALA ASP LYS ALA ALA CYS LEU LEU PRO LYS LEU SEQRES 15 A 585 ASP GLU LEU ARG ASP GLU GLY LYS ALA SER SER ALA LYS SEQRES 16 A 585 GLN ARG LEU LYS CYS ALA SER LEU GLN LYS PHE GLY GLU SEQRES 17 A 585 ARG ALA PHE LYS ALA TRP ALA VAL ALA ARG LEU SER GLN SEQRES 18 A 585 ARG PHE PRO LYS ALA GLU PHE ALA GLU VAL SER LYS LEU SEQRES 19 A 585 VAL THR ASP LEU THR LYS VAL HIS THR GLU CYS CYS HIS SEQRES 20 A 585 GLY ASP LEU LEU GLU CYS ALA ASP ASP ARG ALA ASP LEU SEQRES 21 A 585 ALA LYS TYR ILE CYS GLU ASN GLN ASP SER ILE SER SER SEQRES 22 A 585 LYS LEU LYS GLU CYS CYS GLU LYS PRO LEU LEU GLU LYS SEQRES 23 A 585 SER HIS CYS ILE ALA GLU VAL GLU ASN ASP GLU MET PRO SEQRES 24 A 585 ALA ASP LEU PRO SER LEU ALA ALA ASP PHE VAL GLU SER SEQRES 25 A 585 LYS ASP VAL CYS LYS ASN TYR ALA GLU ALA LYS ASP VAL SEQRES 26 A 585 PHE LEU GLY MET PHE LEU TYR GLU TYR ALA ARG ARG HIS SEQRES 27 A 585 PRO ASP TYR SER VAL VAL LEU LEU LEU ARG LEU ALA LYS SEQRES 28 A 585 THR TYR GLU THR THR LEU GLU LYS CYS CYS ALA ALA ALA SEQRES 29 A 585 ASP PRO HIS GLU CYS TYR ALA LYS VAL PHE ASP GLU PHE SEQRES 30 A 585 LYS PRO LEU VAL GLU GLU PRO GLN ASN LEU ILE LYS GLN SEQRES 31 A 585 ASN CYS GLU LEU PHE GLU GLN LEU GLY GLU TYR LYS PHE SEQRES 32 A 585 GLN ASN ALA LEU LEU VAL ARG TYR THR LYS LYS VAL PRO SEQRES 33 A 585 GLN VAL SER THR PRO THR LEU VAL GLU VAL SER ARG ASN SEQRES 34 A 585 LEU GLY LYS VAL GLY SER LYS CYS CYS LYS HIS PRO GLU SEQRES 35 A 585 ALA LYS ARG MET PRO CYS ALA GLU ASP TYR LEU SER VAL SEQRES 36 A 585 VAL LEU ASN GLN LEU CYS VAL LEU HIS GLU LYS THR PRO SEQRES 37 A 585 VAL SER ASP ARG VAL THR LYS CYS CYS THR GLU SER LEU SEQRES 38 A 585 VAL ASN ARG ARG PRO CYS PHE SER ALA LEU GLU VAL ASP SEQRES 39 A 585 GLU THR TYR VAL PRO LYS GLU PHE ASN ALA GLU THR PHE SEQRES 40 A 585 THR PHE HIS ALA ASP ILE CYS THR LEU SER GLU LYS GLU SEQRES 41 A 585 ARG GLN ILE LYS LYS GLN THR ALA LEU VAL GLU LEU VAL SEQRES 42 A 585 LYS HIS LYS PRO LYS ALA THR LYS GLU GLN LEU LYS ALA SEQRES 43 A 585 VAL MET ASP ASP PHE ALA ALA PHE VAL GLU LYS CYS CYS SEQRES 44 A 585 LYS ALA ASP ASP LYS GLU THR CYS PHE ALA GLU GLU GLY SEQRES 45 A 585 LYS LYS LEU VAL ALA ALA SER GLN ALA ALA LEU GLY LEU SEQRES 1 H 233 GLU VAL GLN LEU LEU GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 233 PRO GLY GLY SER LEU ARG LEU SER CYS ALA VAL SER GLY SEQRES 3 H 233 ILE ASP LEU SER ASN TYR ALA ILE ASN TRP VAL ARG GLN SEQRES 4 H 233 ALA PRO GLY LYS GLY LEU GLU TRP ILE GLY ILE ILE TRP SEQRES 5 H 233 ALA SER GLY THR THR PHE TYR ALA THR TRP ALA LYS GLY SEQRES 6 H 233 ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR VAL SEQRES 7 H 233 TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR ALA SEQRES 8 H 233 VAL TYR TYR CYS ALA ARG THR VAL PRO GLY TYR SER THR SEQRES 9 H 233 ALA PRO TYR PHE ASP LEU TRP GLY GLN GLY THR LEU VAL SEQRES 10 H 233 THR VAL SER SER ALA SER THR LYS GLY PRO SER VAL PHE SEQRES 11 H 233 PRO LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR SEQRES 12 H 233 ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU SEQRES 13 H 233 PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER SEQRES 14 H 233 GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY SEQRES 15 H 233 LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SEQRES 16 H 233 SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS SEQRES 17 H 233 LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO SEQRES 18 H 233 LYS SER CYS ASP LYS THR HIS HIS HIS HIS HIS HIS SEQRES 1 L 217 ASP ILE GLN MET THR GLN SER PRO SER SER VAL SER ALA SEQRES 2 L 217 SER VAL GLY ASP ARG VAL THR ILE THR CYS GLN SER SER SEQRES 3 L 217 PRO SER VAL TRP SER ASN PHE LEU SER TRP TYR GLN GLN SEQRES 4 L 217 LYS PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR GLU ALA SEQRES 5 L 217 SER LYS LEU THR SER GLY VAL PRO SER ARG PHE SER GLY SEQRES 6 L 217 SER GLY SER GLY THR ASP PHE THR LEU THR ILE SER SER SEQRES 7 L 217 LEU GLN PRO GLU ASP PHE ALA THR TYR TYR CYS GLY GLY SEQRES 8 L 217 GLY TYR SER SER ILE SER ASP THR THR PHE GLY GLY GLY SEQRES 9 L 217 THR LYS VAL GLU ILE LYS ARG THR VAL ALA ALA PRO SER SEQRES 10 L 217 VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER SEQRES 11 L 217 GLY THR ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR SEQRES 12 L 217 PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA SEQRES 13 L 217 LEU GLN SER GLY ASN SER GLN GLU SER VAL THR GLU GLN SEQRES 14 L 217 ASP SER LYS ASP SER THR TYR SER LEU SER SER THR LEU SEQRES 15 L 217 THR LEU SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR SEQRES 16 L 217 ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL SEQRES 17 L 217 THR LYS SER PHE ASN ARG GLY GLU CYS HELIX 1 1 SER A 5 GLY A 15 1 11 HELIX 2 2 GLY A 15 LEU A 31 1 17 HELIX 3 3 PRO A 35 ALA A 55 1 21 HELIX 4 4 SER A 65 CYS A 75 1 11 HELIX 5 5 GLU A 86 ALA A 92 1 7 HELIX 6 6 PRO A 96 HIS A 105 1 10 HELIX 7 7 GLU A 119 ASN A 130 1 12 HELIX 8 8 ASN A 130 HIS A 146 1 17 HELIX 9 9 TYR A 150 CYS A 169 1 20 HELIX 10 10 ASP A 173 PHE A 223 1 51 HELIX 11 11 GLU A 227 HIS A 247 1 21 HELIX 12 12 ASP A 249 ASN A 267 1 19 HELIX 13 13 GLN A 268 ILE A 271 5 4 HELIX 14 14 PRO A 282 VAL A 293 1 12 HELIX 15 15 LEU A 305 VAL A 310 1 6 HELIX 16 16 ASP A 314 ALA A 322 1 9 HELIX 17 17 ALA A 322 ARG A 337 1 16 HELIX 18 18 SER A 342 CYS A 361 1 20 HELIX 19 19 ASP A 365 TYR A 370 1 6 HELIX 20 20 LYS A 372 VAL A 415 1 44 HELIX 21 21 SER A 419 CYS A 438 1 20 HELIX 22 22 LYS A 444 THR A 467 1 24 HELIX 23 23 SER A 470 GLU A 479 1 10 HELIX 24 24 ASN A 483 LEU A 491 1 9 HELIX 25 25 HIS A 510 LEU A 516 5 7 HELIX 26 26 SER A 517 LYS A 536 1 20 HELIX 27 27 GLN A 543 CYS A 559 1 17 HELIX 28 28 GLU A 565 LYS A 574 1 10 HELIX 29 29 LEU A 575 GLN A 580 1 6 HELIX 30 30 ARG H 86 THR H 90 5 5 HELIX 31 31 SER H 164 ALA H 166 5 3 HELIX 32 32 PRO H 193 SER H 196 5 4 HELIX 33 33 LYS H 209 ASN H 212 5 4 HELIX 34 34 GLN L 80 PHE L 84 5 5 HELIX 35 35 SER L 124 LYS L 129 1 6 HELIX 36 36 LYS L 186 LYS L 191 1 6 SHEET 1 HA 4 GLN H 3 SER H 7 0 SHEET 2 HA 4 LEU H 18 SER H 25 -1 O SER H 21 N SER H 7 SHEET 3 HA 4 THR H 77 MET H 82 -1 O VAL H 78 N CYS H 22 SHEET 4 HA 4 PHE H 67 ASP H 72 -1 O THR H 68 N GLN H 81 SHEET 1 HB 6 LEU H 11 VAL H 12 0 SHEET 2 HB 6 THR H 115 VAL H 119 1 O THR H 118 N VAL H 12 SHEET 3 HB 6 ALA H 91 ARG H 97 -1 O ALA H 91 N VAL H 117 SHEET 4 HB 6 ILE H 34 GLN H 39 -1 O ASN H 35 N ALA H 96 SHEET 5 HB 6 GLU H 46 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 HB 6 THR H 57 TYR H 59 -1 O PHE H 58 N ILE H 50 SHEET 1 HC 4 SER H 128 PRO H 131 0 SHEET 2 HC 4 ALA H 145 TYR H 153 -1 O LEU H 149 N PHE H 130 SHEET 3 HC 4 TYR H 184 THR H 191 -1 O TYR H 184 N TYR H 153 SHEET 4 HC 4 VAL H 177 LEU H 178 1 O VAL H 177 N SER H 185 SHEET 1 HD 4 SER H 128 PRO H 131 0 SHEET 2 HD 4 ALA H 145 TYR H 153 -1 O LEU H 149 N PHE H 130 SHEET 3 HD 4 TYR H 184 THR H 191 -1 O TYR H 184 N TYR H 153 SHEET 4 HD 4 VAL H 171 THR H 173 -1 O HIS H 172 N VAL H 189 SHEET 1 HE 2 VAL H 177 LEU H 178 0 SHEET 2 HE 2 TYR H 184 THR H 191 1 O SER H 185 N VAL H 177 SHEET 1 HF 3 THR H 159 TRP H 162 0 SHEET 2 HF 3 ILE H 203 HIS H 208 -1 O ASN H 205 N SER H 161 SHEET 3 HF 3 THR H 213 LYS H 218 -1 O THR H 213 N HIS H 208 SHEET 1 LA 4 MET L 4 SER L 7 0 SHEET 2 LA 4 VAL L 19 SER L 25 -1 O THR L 22 N SER L 7 SHEET 3 LA 4 ASP L 71 ILE L 76 -1 O PHE L 72 N CYS L 23 SHEET 4 LA 4 PHE L 63 SER L 68 -1 O SER L 64 N THR L 75 SHEET 1 LB 4 VAL L 11 SER L 14 0 SHEET 2 LB 4 THR L 105 LYS L 110 1 O LYS L 106 N VAL L 11 SHEET 3 LB 4 ALA L 85 GLY L 91 -1 O ALA L 85 N VAL L 107 SHEET 4 LB 4 THR L 100 PHE L 101 -1 O THR L 100 N GLY L 91 SHEET 1 LC 6 VAL L 11 SER L 14 0 SHEET 2 LC 6 THR L 105 LYS L 110 1 O LYS L 106 N VAL L 11 SHEET 3 LC 6 ALA L 85 GLY L 91 -1 O ALA L 85 N VAL L 107 SHEET 4 LC 6 LEU L 34 GLN L 39 -1 O SER L 35 N GLY L 90 SHEET 5 LC 6 PRO L 45 TYR L 50 -1 O LYS L 46 N GLN L 38 SHEET 6 LC 6 LYS L 54 LEU L 55 -1 O LYS L 54 N TYR L 50 SHEET 1 LD 2 THR L 100 PHE L 101 0 SHEET 2 LD 2 ALA L 85 GLY L 91 -1 O GLY L 91 N THR L 100 SHEET 1 LE 4 SER L 117 VAL L 118 0 SHEET 2 LE 4 THR L 132 PHE L 142 -1 O ASN L 140 N SER L 117 SHEET 3 LE 4 TYR L 176 SER L 185 -1 O TYR L 176 N PHE L 142 SHEET 4 LE 4 SER L 162 VAL L 166 -1 O GLN L 163 N THR L 181 SHEET 1 LF 4 ALA L 156 LEU L 157 0 SHEET 2 LF 4 ALA L 147 VAL L 153 -1 O VAL L 153 N ALA L 156 SHEET 3 LF 4 VAL L 194 HIS L 201 -1 O ALA L 196 N LYS L 152 SHEET 4 LF 4 VAL L 208 THR L 209 -1 O VAL L 208 N VAL L 199 SHEET 1 LG 4 ALA L 156 LEU L 157 0 SHEET 2 LG 4 ALA L 147 VAL L 153 -1 O VAL L 153 N ALA L 156 SHEET 3 LG 4 VAL L 194 HIS L 201 -1 O ALA L 196 N LYS L 152 SHEET 4 LG 4 PHE L 212 ASN L 213 -1 O PHE L 212 N TYR L 195 SHEET 1 LH 2 VAL L 208 THR L 209 0 SHEET 2 LH 2 VAL L 194 HIS L 201 -1 N VAL L 199 O VAL L 208 SSBOND 1 CYS A 53 CYS A 62 1555 1555 2.02 SSBOND 2 CYS A 75 CYS A 91 1555 1555 2.04 SSBOND 3 CYS A 90 CYS A 101 1555 1555 2.03 SSBOND 4 CYS A 124 CYS A 169 1555 1555 2.03 SSBOND 5 CYS A 168 CYS A 177 1555 1555 2.03 SSBOND 6 CYS A 200 CYS A 246 1555 1555 2.03 SSBOND 7 CYS A 245 CYS A 253 1555 1555 2.03 SSBOND 8 CYS A 265 CYS A 279 1555 1555 2.02 SSBOND 9 CYS A 278 CYS A 289 1555 1555 2.03 SSBOND 10 CYS A 316 CYS A 361 1555 1555 2.03 SSBOND 11 CYS A 360 CYS A 369 1555 1555 2.01 SSBOND 12 CYS A 392 CYS A 438 1555 1555 2.04 SSBOND 13 CYS A 437 CYS A 448 1555 1555 2.04 SSBOND 14 CYS A 461 CYS A 477 1555 1555 2.02 SSBOND 15 CYS A 476 CYS A 487 1555 1555 2.04 SSBOND 16 CYS A 514 CYS A 559 1555 1555 2.04 SSBOND 17 CYS A 558 CYS A 567 1555 1555 2.03 SSBOND 18 CYS H 22 CYS H 95 1555 1555 2.02 SSBOND 19 CYS H 148 CYS H 204 1555 1555 2.03 SSBOND 20 CYS L 23 CYS L 89 1555 1555 2.03 SSBOND 21 CYS L 137 CYS L 197 1555 1555 2.04 CISPEP 1 GLU A 95 PRO A 96 0 -0.08 CISPEP 2 PHE H 154 PRO H 155 0 0.04 CISPEP 3 GLU H 156 PRO H 157 0 -0.12 CISPEP 4 SER L 7 PRO L 8 0 -0.12 CISPEP 5 TYR L 143 PRO L 144 0 0.30 CRYST1 217.640 217.640 78.650 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004595 0.002653 0.000000 0.00000 SCALE2 0.000000 0.005306 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012715 0.00000